IMUC Related New Coverage
-
Roth Capital Starts ImmunoCellular Therapeutics (IMUC) at Buy
-
ImmunoCellular Therapeutics (IMUC) Ramps on New Buy Rating
-
McNicoll Lewis & Vlak Starts ImmunoCellular Therapeutics (IMUC) at Buy
-
Global Hunter Securities Starts ImmunoCellular Therapeutics (IMUC) at Buy; Compelling Value Proposition in Cancer Immunotherapy Group
Back to IMUC Stock Lookup
